Executive record

Gregory Moss

Director at Anteris Technologies Global Corp.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:gregory-mossVersion: public-0As of: 2026-09-29

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Gregory Moss serves as Chief Business and Legal Officer of Evommune, Inc. He previously served as Executive Vice President, General Counsel, and Corporate Secretary at Kadmon (acquired by Sanofi for $1.9 billion in 2021), where he led legal, compliance, and business development operations. He has legal experience in corporate risk and complex litigation.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Chief Business and Legal Officer · Organization not publishedAVR DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. AVR DEF 14A director slate

    sec filing · Source published: Nov 10, 2025 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Nominating and Corporate Governance Committee · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Evommune, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Business and Legal Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Nov 10, 2025 · Retrieved: Apr 25, 2026

    Supports 1 claim
    • Professional Role: Director at Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Anteris Technologies Global Corp. · Claim reviewed: May 15, 2026